A core strategic question facing life sciences companies developing novel AI-implemented methods is whether to file for patent protection or to keep the methods as trade secret.
One successful approach is to develop a hybrid strategy for patents and trade secrets based on current and future company goals, following the considerations outlined below.
Read the full blog post.